Testing a questionnaire for urinary incontinence in women
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a new questionnaire (called PRAFAB) to see if it is a valid and reliable way to measure how urinary incontinence affects your daily life. The goal is to have a better tool for doctors to understand and help patients with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with urinary incontinence (leaking urine) by a doctor
- You are female
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called PEASY for collecting urine in men who have trouble controlling their bladder. It aims to see how well it works, if it's safe, and if it's comfortable to use.
This trial builds a “database” to better understand why some people have stool (faecal) leakage versus double incontinence (urine plus stool). It asks about symptoms and performs a rectal pressure test to see which factors are linked to different types of leakage.
This study compares two ways to help women learn how to tighten the pelvic floor muscles. It may help women with pelvic floor problems and urinary leaking by improving muscle control using either biofeedback or clinician guidance.
This study compares two ways to help women with overactive bladder get treatment and stick with it. You might be able to join if you are a woman with ongoing OAB symptoms and haven't had certain treatments recently.
This study tests a new treatment for urinary incontinence in women. It looks at how well the treatment works and if it is safe for Chinese women who have had this problem.
This trial tests whether physiotherapy can help women with urinary incontinence. It compares a treatment group to a group of healthy women.
Hear when a new Urinary Incontinence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.